EODData

MEMBERSHIP REGISTER LOG IN

LSE, 0RC7: Hansa Medical AB

29 Dec 2025
LAST:

32.90

CHANGE:
 1.54		OPEN:
32.34		HIGH:
32.90		ASK:
0.00		VOLUME:
812
CHG(%):
4.91		PREV:
31.36		LOW:
32.34		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
29 Dec 2532.3432.9032.3432.90812
26 Dec 2530.6031.2431.2431.361.4K
25 Dec 2530.6031.2431.2431.361.4K
24 Dec 2531.3631.3631.3631.361
23 Dec 2531.2431.3631.2431.361.4K
22 Dec 2531.5231.5229.8530.338.2K
19 Dec 2529.1029.3029.0029.10860
18 Dec 2528.0729.0627.7528.456.1K
17 Dec 2524.0627.8624.0627.7710.5K
16 Dec 2534.5434.6233.2633.762.8K

PROFILE

Name:Hansa Medical AB
About:Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe. The company offers Idefirix(imlifidase), which targets and cleaves all classes of immunoglobulin G (IgG) antibodies for the desensitization treatment of sensitized adult kidney transplant patients with a positive crossmatch test. It is also developing HNSA-5487, a next generation IgG-cleaving enzyme to address acute and chronic neuro-autoimmune conditions, including myasthenia gravis. In addition, the company evaluates imlifidase in three therapy areas, including autoimmune, gene therapy, and transplantation. It has a collaboration agreement with Sarepta Therapeutics to assess imlifidase as a pre-treatment in limb-girdle muscular dystrophy (LGMD) and duchenne muscular dystrophy (DMD); AskBio to evaluate imlifidase as a pre-treatment in pompe disease; and research and development collaboration agreement with Genethon to evaluate the safety and efficacy of imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies. Hansa Biopharma AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Address:ScheelevAegen 22, Lund, Sweden, 223 63
Website:https://www.hansabiopharma.com

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-2.44 
PEG Ratio:0.10 
Price to Sales:13.00 
Price to Book:9.03 
Profit Margin:0.51 
Operating Margin:-4.31 
Return on Assets:-0.40 
Return on Equity:-2.29 
Revenue:158.7M 

TECHNICAL INDICATORS

MA5:31.673.9%
MA10:30.786.9%
MA20:32.411.5%
MA50:31.006.1%
MA100:32.381.6%
MA200:28.7914.3%
STO9:100.00 
STO14:58.90
RSI14:43.32
WPR14:-40.42
MTM14:-2.12
ROC14:-0.06 
ATR:1.61 
Week High:32.900.0%
Week Low:29.8510.2%
Month High:36.4810.9%
Month Low:24.0614.3%
Year High:42.9630.6%
Year Low:20.1063.7%